Smith–Fineman–Myers syndrome
Smith–Fineman–Myers syndrome (SFMS) is a rare genetic disorder characterized by a combination of distinctive facial features, developmental delays, and other physical abnormalities. It is also known as Smith-Fineman-Myers syndrome or SFMS. The syndrome is named after the researchers who first described it.
Signs and Symptoms[edit | edit source]
Individuals with Smith–Fineman–Myers syndrome typically present with a range of symptoms, which may include:
- Microcephaly (abnormally small head size)
- Intellectual disability
- Hypotonia (reduced muscle tone)
- Distinctive facial features such as a broad nasal bridge, upturned nose, and a prominent forehead
- Growth retardation
- Seizures
- Congenital heart defects
Genetics[edit | edit source]
Smith–Fineman–Myers syndrome is believed to be inherited in an X-linked recessive pattern. This means that the gene responsible for the disorder is located on the X chromosome, and the condition is more commonly seen in males. Females who carry one copy of the mutated gene typically do not show symptoms but can pass the gene to their offspring.
Diagnosis[edit | edit source]
The diagnosis of Smith–Fineman–Myers syndrome is based on clinical evaluation, identification of characteristic physical findings, and genetic testing. Molecular genetic testing can confirm the diagnosis by identifying mutations in the gene associated with the syndrome.
Treatment[edit | edit source]
There is no cure for Smith–Fineman–Myers syndrome. Treatment is symptomatic and supportive, focusing on managing the individual symptoms and improving the quality of life for affected individuals. This may include:
- Physical therapy to improve muscle tone and coordination
- Speech therapy to address communication difficulties
- Occupational therapy to assist with daily living skills
- Anticonvulsant medications to control seizures
- Regular monitoring and treatment of congenital heart defects
Prognosis[edit | edit source]
The prognosis for individuals with Smith–Fineman–Myers syndrome varies depending on the severity of symptoms and the presence of associated health issues. Early intervention and supportive care can help improve outcomes and quality of life.
Related Pages[edit | edit source]
- Genetic disorder
- Microcephaly
- Intellectual disability
- Hypotonia
- X-linked recessive inheritance
- Congenital heart defect
References[edit | edit source]
External Links[edit | edit source]
-
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD